RxDoctor Payments Data

Ashleigh Hudson

Family · Rocky Mount, NCNPI 1093413098

Payments from drug & device makers

$1,768in general payments, 2019–2025

Across 96 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$289
  • AstraZeneca$215
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$205
  • E.r. Squibb & Sons, L.L.C.$190
  • Pfizer$189
  • Alnylam Pharmaceuticals Inc.$147
  • plus $532 from 12 others

What the payments were for

  • Food & beverage$1,768100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,768 in reported general payments places this provider in the 80th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$42,446
Medicare patients
160
Services billed
775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan420$294,455
JardianceEmpagliflozin244$208,871
FarxigaDapagliflozin Propanediol121$96,960
EliquisApixaban75$50,062
XareltoRivaroxaban15$8,249
Torsemide269$7,266
Metoprolol Succinate408$3,277
Spironolactone516$2,169
Isosorbide Dinit-HydralazineIsosorbide Dinit/Hydralazine22$1,842
Furosemide453$1,726
Losartan Potassium191$1,137
Carvedilol207$998
Hydralazine Hcl83$805
Bumetanide25$742
Atorvastatin Calcium72$569

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$289$294,455420 claims
Boehringer IngelheimJardiance$88$208,871244 claims
AstraZenecaFarxiga$215$96,960121 claims
PfizerEliquis$189$50,06275 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,522 family providers in North Carolina.

Other family in Rocky Mount

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →